Published: March 5th 2024 | Updated: September 8th 2024
FDA Approves First Denosumab Biosimilars
Published: September 2nd 2024 | Updated: September 8th 2024
Biosimilar Uptake Lags in US Despite Potential Cost Savings
Published: August 29th 2024 | Updated: September 8th 2024
Prioritizing Patient-Centered Care in PsA: Key Insights From the 2023 EULAR Guidelines
Published: August 26th 2024 | Updated: September 8th 2024
BioRationality: FDA Opens Up Biosimilar Inquiries on Reddit
Published: August 19th 2024 | Updated: September 8th 2024
CMS Announces New Drug Prices Under the IRA, Including for Stelara and Enbrel
Published: August 18th 2024 | Updated: September 8th 2024
Patent Dance Insights: A Q&A on Reducing Legal Battles in the Biosimilar Landscape